Abstract:Early precise diagnosis of cancers is crucial to realize more effective therapeutic interventions with minimal toxic effects. Cancer phenotypes may also alter greatly among patients and within individuals over therapeutic process. The identification and characterization of specific biomarkers expressed on tumor cells are highly demanded for diagnosis and treatment, but remain ongoing challenge. Herein, we designed three new bioorthogonal surface enhanced Raman scattering (SERS) nanoprobes and successfully applied the cocktail of them for MDA-MB-231 and MCF-7 breast cancer multiplex phenotype detection. The SERS nanoprobes containing Raman reporters with diynl, azide or cyano moieties demonstrated apparent Raman shift peaks in 2205 cm-1, 2120 cm-1 and 2230 cm-1, respectively, in biologically Raman-silent region. Three target ligands including oligonucleotide aptamer (AS1411), arginine-glycine-aspatic acid (RGD) peptide and homing cell adhesion molecule antibody (anti-CD44) were respectively conjugated to the nanoprobes for active recognition capability. The cocktail of the nanoprobes manifested minimal cytotoxicity and simultaneously multiplex phenotype imaging of MDA-MB-231 and MCF-7 cells. Quantitative measurement of cellular uptake by in-ductively coupled plasma mass spectrometry (ICP-MS) verified that MDA-MB-231 cells harbored much higher expres-sion level of CD44 receptor than MCF-7 cells. For in vivo SERS detection, Raman shift peaks of 2120 cm-1, 2205 cm-1 and 2230 cm-1 in micro tumor were clearly observed, representing the existence of three specific biomarkers of nucleolin, integrin αvβ3 and CD44 reporter, which could be used for early cancer phenotype identification. The biodistribution results indicated that target ligand modified nanoprobes exhibited much more accumulation in tumors than those nanoprobes without target ligands. The multicolor cocktail of bioorthogonal SERS nanoprobes offers an attractive and insightful strategy for early cancer multiplex phenotype targeting and diagnosis in vivo with non-invasion, low cross-talk, unique spectral-molecular signature, high sensitivity and negligible background interference.

Fine Synthesis of Prussian-blue Analogue Coated Gold Nanoparticles (au@pba NPs) for Sorting Specific Cancer Cell Subtypes.

Monodisperse Au@Ag core-shell nanoprobes with ultrasensitive SERS-activity for rapid identification and Raman imaging of living cancer cells.

Alkyne- and Nitrile-Anchored Gold Nanoparticles for Multiplex SERS Imaging of Biomarkers in Cancer Cells and Tissues.

Synergistic Enhancement of Ultrahigh SERS Activity Via Cu2O@Ag Core-Shell Structure for Accurate Label-Free Identification of Breast Tumor Subtypes

Surface-Enhanced Raman Scattering Active Plasmonic Nanoparticles with Ultrasmall Interior Nanogap for Multiplex Quantitative Detection and Cancer Cell Imaging

Au@Ag-Au Core@double Shell SERS Bioprobes for High-Resolution Tumor Cells Imaging

Bioconjugation of Gold Nanobipyramids for SERS Detection and Targeted Photothermal Therapy in Breast Cancer.

Distinguishing breast cancer cells using surface-enhanced Raman scattering

Multicolor Cocktail for Breast Cancer Multiplex Phenotype Targeting and Diagnosis Using Bioorthogonal Surface-Enhanced Raman Scattering Nanoprobes.

Bioorthogonal Surface-Enhanced Raman Scattering Flower-Like Nanoprobe with Embedded Standards for Accurate Cancer Cell Imaging

Surface Enhanced Raman Scattering Probes Based on Antibody Conjugated Au Nanostars for Distinguishing Lung Cancer Cells from Normal Cells

When Prussian Blue Meets Porous Gold Nanoparticles: A High Signal-to-Background Surface-Enhanced Raman Scattering Probe for Cellular Biomarker Imaging

Gold Nanoparticle (Aunp)-Based Surface-Enhanced Raman Scattering (SERS) Probe of Leukemic Lymphocytes

Synthesis of raspberry-like nanogapped Fe3O4@Au nanocomposites for SERS-based lateral flow detection of multiple tumor biomarkers

Highly narrow nanogap-containing Au@Au core–shell SERS nanoparticles: size-dependent Raman enhancement and applications in cancer cell imaging

Bioorthogonal SERS Nanoprobes for Mulitplex Spectroscopic Detection, Tumor Cell Targeting, and Tissue Imaging.

Application of Dual-Enhanced Surface-Enhanced Raman Scattering Probe Technology in the Diagnosis of Tumor Cells In Vitro

Precise and Label-Free Tumour Cell Recognition Based on a Black Phosphorus Nanoquenching Platform.

Precise diagnosis of tumor cells and hemocytes using ultrasensitive, stable, selective cuprous oxide composite SERS bioprobes assisted with high-efficiency separation microfluidic chips

Bovine serum albumin-gold nanoclusters protein corona stabilized polystyrene nanoparticles as dual-color fluorescent nanoprobes for breast cancer detection.

SERS Nanoprobes in Biologically Raman Silent Region for Tumor Cell Imaging and in Vivo Tumor Spectral Detection in Mice